Skip to main content
Premium Trial:

Request an Annual Quote

IP Watch: Qiagen, Illumina, Canon, Others Win US Patents


The Regents of the University of California have been awarded US Patent No. 8,778,608, "CA9 gene single nucleotide polymorphisms predict prognosis and treatment response of metastatic renal cell carcinoma."

Arie Belldegrun and Allan Pantuck are named as inventors.

Good Start Genetics has been awarded US Patent No. 8,778,609, "Methods for analyzing nucleic acids."

Mark Umbarger is named as the inventor.

Rubicon Genomics has been awarded US Patent No. 8,778,610, "Methods for preparing amplifiable DNA molecules."

Vladimir Makarov, Emmanuel Kamberov, and Brendan Tarrier are named as inventors.

Canon US Life Sciences has been awarded US Patent No. 8,778,637, "Method and apparatus for applying continuous flow and uniform temperature to generate thermal melting curves in a microfluidic device."

Ivor Knight and Deborah Boyles are named as inventors.

Lawrence Livermore National Security has been awarded US Patent No. 8,778,663, "Thermal cycler."

William Benett, John Andreski, John Dzenitis, Anthony Makarewicz, Dean Hadley, and Satinderpall Pannu are named as inventors.

Qiagen has been awarded US Patent No. 8,778,842, "Sample lysis and coating of reaction surface."

Ralf Himmelreich, Roland Fabis, Christoph Erbacher, Sabine Werner, and Bernd Springer are named as inventors.

Illumina has been awarded US Patent No. 8,778,848, "Patterned flow-cells useful for nucleic acid analysis."

Shengrong Lin, Yir-Shyuan Wu, Kevin Gunderson, and John Moon are named as inventors.